Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors.
Lin-Ying XiaRong YangYa-Liang ZhangYi-Chun ChuYa-Lin QiRuo-Jun ManZhong-Chang WangBao-Zhong WangHai-Liang ZhuPublished in: Chemical biology & drug design (2019)
Several novel cycloalkyl-fused 2,3-diaryl pyrazole derivatives were designed, synthesized, and evaluated as potential anti-tubulin agents. Compound A10 exhibited the most potent antiproliferative activity against a panel of cancer lines (IC50 = 0.78-2.42 μM) and low cytotoxicity against 293T & L02 (CC50 values of 131.74 and 174.89 μM, respectively). Moreover, A10 displayed inhibition of tubulin polymerization in vitro, arrested the G2/M phase of the cell cycle, changed morphology of tubulin, increased intracellular reactive oxygen species, and induced apoptosis of HeLa cells. Docking simulation and 3D-QSAR models were performed to elaborate on the anti-tubulin mechanism of the derivatives. The inhibition of monoclonal colony formation provided more intuitional data to verify the possibility of A10 as a novel tubulin assembling inhibitor.
Keyphrases
- induced apoptosis
- cell cycle
- endoplasmic reticulum stress
- reactive oxygen species
- molecular docking
- signaling pathway
- oxidative stress
- cell proliferation
- molecular dynamics
- cell cycle arrest
- structure activity relationship
- molecular dynamics simulations
- machine learning
- risk assessment
- small molecule
- papillary thyroid
- electronic health record
- young adults
- squamous cell
- lymph node metastasis